Delayed and clinically isolated port site carcinosarcoma recurrence as an early indicator of disseminated disease

Por Dandapani, Monica, Seagle, Brandon-Luke L., Chacho, Mary S., Shahabi, Shohreh
Publicado no Gynecol Oncol Rep (2015)

Epothilone B Enhances Surface EpCAM Expression in Ovarian Cancer Hey Cells

Por Shahabi, Shohreh, Yang, Chia-Ping Huang, Goldberg, Gary L., Horwitz, Susan Band
Publicado em 2010

Human Papillomavirusassociated Cancers as Acquired Immunodeficiency Syndrome Defining Illnesses

Por Falter II, Keith J., Frimer, Marina, Lavy, Dan, Samuelson, Robert, Shahabi, Shohreh
Publicado em 2013

Presence of both Mesenchymal and Carcinomatous Features in an In-vitro Model of Ovarian Carcinosarcoma Derived from Patients' Ascitic Fluid

Por Shariftabrizi, Ahmad, Pellicciotta, Ilenia, Abdullah, Amer, Venditti, Charis Anne, Samuelson, Robert, Shahabi, Shohreh
Publicado no Int J Hematol Oncol Stem Cell Res (2015)

Free Testosterone Drives Cancer Aggressiveness: Evidence from US Population Studies

Por Shahabi, Shohreh, He, Shiquan, Kopf, Michael, Mariani, Marisa, Petrini, Joann, Scambia, Giovanni, Ferlini, Cristiano
Publicado em 2013

Response to microtubule-interacting agents in primary epithelial ovarian cancer cells

Por Pellicciotta, Ilenia, Yang, Chia-Ping Huang, Venditti, Charis A, Goldberg, Gary L, Shahabi, Shohreh
Publicado em 2013

The Clinical Relevance of Rising CA-125 Levels Within the Normal Range in Patients With Uterine Papillary Serous Cancer

Por Frimer, Marina, Hou, June Y., McAndrew, Thomas C., Goldberg, Gary L., Shahabi, Shohreh
Publicado em 2013

A Clinical and Pathologic Comparison Between Stage-Matched Endometrial Intraepithelial Carcinoma and Uterine Serous Carcinoma: Is There a Difference?

Por Hou, June Y., McAndrew, Thomas C., Goldberg, Gary L., Whitney, Kathleen, Shahabi, Shohreh
Publicado em 2014

Metastatic Uterine Leiomyosarcoma Involving Bilateral Ovarian Stroma without Capsular Involvement Implies a Local Route of Hematogenous Dissemination

Por Dandapani, Monica, Seagle, Brandon-Luke L., Abdullah, Amer, Hatfield, Bryce, Samuelson, Robert, Shahabi, Shohreh
Publicado no Case Rep Obstet Gynecol (2015)

Clinical utility of chromogranin A and octreotide in large cell neuro endocrine carcinoma of the uterine corpus

Por Shahabi, Shohreh, Pellicciotta, Ilenia, Hou, June, Graceffa, Sarah, Huang, Gloria S., Samuelson, Robert N., Goldberg, Gary L.
Publicado em 2011

Mullerian adenosarcoma of the cervix: Report of two large tumors with sarcomatous overgrowth or heterologous elements

Por Seagle, Brandon-Luke L., Falter, Keith J., Lee, Stephen J., Frimer, Marina, Samuelson, Robert, Shahabi, Shohreh
Publicado no Gynecol Oncol Case Rep (2014)

Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers

Por Seagle, Brandon-Luke L., Eng, Kevin H., Dandapani, Monica, Yeh, Judy Y., Odunsi, Kunle, Shahabi, Shohreh
Publicado no Oncotarget (2015)

Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma

Por Ezzati, Mohammad, Abdullah, Amer, Shariftabrizi, Ahmad, Hou, June, Kopf, Michael, Stedman, Jennifer K., Samuelson, Robert, Shahabi, Shohreh
Publicado no Int Sch Res Notices (2014)

MiR-200c and HuR in ovarian cancer

Por Prislei Silvia, Martinelli Enrica, Mariani Marisa, Raspaglio Giuseppina, Sieber Steven, Ferrandina Gabriella, Shahabi Shohreh, Scambia Giovanni, Ferlini Cristiano
Publicado em 2013-02-01

Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo?

Por Baranello, Cinzia, Mariani, Marisa, Andreoli, Mirko, Fanelli, Mara, Martinelli, Enrica, Ferrandina, Gabriella, Scambia, Giovanni, Shahabi, Shohreh, Ferlini, Cristiano
Publicado em 2012

MiR-200c and HuR in ovarian cancer

Por Prislei, Silvia, Martinelli, Enrica, Mariani, Marisa, Raspaglio, Giuseppina, Sieber, Steven, Ferrandina, Gabriella, Shahabi, Shohreh, Scambia, Giovanni, Ferlini, Cristiano
Publicado em 2013

Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer

Por Seagle, Brandon-Luke L., Eng, Kevin H., Yeh, Judy Y., Dandapani, Monica, Schiller, Emily, Samuelson, Robert, Odunsi, Kunle, Shahabi, Shohreh
Publicado no Sci Rep (2016)

Integrated Multidimensional Analysis Is Required for Accurate Prognostic Biomarkers in Colorectal Cancer

Por Mariani, Marisa, He, Shiquan, McHugh, Mark, Andreoli, Mirko, Pandya, Deep, Sieber, Steven, Wu, Zheyang, Fiedler, Paul, Shahabi, Shohreh, Ferlini, Cristiano
Publicado em 2014

A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers()

Por Gupta, Divya, Owers, Ricky L., Kim, Mimi, Kuo, Dennis Yi-Shin, Huang, Gloria S., Shahabi, Shohreh, Goldberg, Gary L., Einstein, Mark H.
Publicado no Gynecol Oncol (2009)

HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancer

Por Mariani, Marisa, McHugh, Mark, Petrillo, Marco, Sieber, Steven, He, Shiquan, Andreoli, Mirko, Wu, Zheyang, Fiedler, Paul, Scambia, Giovanni, Shahabi, Shohreh, Ferlini, Cristiano
Publicado em 2014